Search
for
Sort by
Research 181–210 of 182
- Advances in skin grafting and treatment of cutaneous wounds
- Cytoprotectivity of the natural honey against the toxic effects of Doxorubicin in mice
- PSS21 GAP ANALYSIS FOR PATIENT-REPORTED OUTCOMES MEASURES FOR ALOPECIA
- Measuring Patient Quality of Life Following Treatment for Alopecia
- Alopecia Areata
- Evidence-based approach to cutaneous hyperandrogenism in women
- Hair loss in elderly women
- Acne severity and the Global Acne Grading System in polycystic ovary syndrome
- Female pattern alopecia: current perspectives
- Androgenetic Alopecia: A Review
- The Relationship Between Acne and Other Hyperandrogenism Signs
- Chronic inflammatory diseases are stimulated by current lifestyle: how diet, stress levels and medication prevent our body from recovering
- The role of platelet-rich plasma in biomedicine: A comprehensive overview
- Female Pattern Hair Loss
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- Systemic causes of hair loss
- DERMATOLOGIC DISEASES AND PROBLEMS OF WOMEN THROUGHOUT THE LIFE CYCLE
- Factors Related to Premature Canities; A Cross-sectional Study in Lagos State, Nigeria
- Health Care-Related Economic Burden of the Polycystic Ovary Syndrome during the Reproductive Life Span
- Methods of Using of Cosmeceuticals in Trichological Practice
- Skin care physicians insight on epidemiological patterns, diagnosis and treatment modalities for female pattern hair loss
- Efficacy and safety of oral spironolactone for female pattern hair loss in premenopausal women: a randomized, double-blind, placebo-controlled, parallel-group pilot study
- Bendamustine: an Old Drug in the New Era for Patients with Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia
- The 46th Annual Meeting of the Irish Endocrine Society Meeting Programme and Abstracts 2022
- The Psychological Impact of Hair Loss Can Be Alleviated
- Chitosan-based nanoformulations for alopecia treatment
- Prevalence of polycystic ovaries in women with androgenic alopecia
- Quantitative assessment of spironolactone treatment in women with diffuse androgen-dependent alopecia
- Metabolic Syndrome, Cardiovascular Disease and the Hair Growth Cycle: Addressing hair growth disruptions using Nourkrin® with Marilex® as a proteoglycan replacement therapy: A concise review
- Female Pattern Hair Loss